Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Taiwan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20052
20062
20072
20082
20091
20101
20131
20141
20172
20182
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi6
Boehringer Ingelheim3
Bristol-Myers Squibb2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Academia Sinica, Taiwan1
AstraZeneca1
Bayer1
CSL Behring1
Chun-Yao Huang1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation22
Stroke6
Atrial Flutter3
Arrhythmias, Cardiac2
Cardiovascular Diseases2
Embolism2
Heart Failure2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.